Obesity

3 articles

Pharmaceutical scientist analyzing molecular data, representing the complex balance between drug efficacy and patient tolerability in obesity treatment.

Boehringer's obesity drug shows efficacy, faces tolerability challenge

In a pivotal Phase 3 obesity trial, 19% of patients on Boehringer Ingelheim and Zealand Pharma's experimental drug survodutide discontinued treatment due to severe gastrointestinal side effects, a rat

Yasmin Haddad·June 8, 2026

Medical and public health experts collaborating on redefining obesity as a complex condition, not a single disease.

Health & Medicine

Obesity disease label challenges clinical definitions and public health

In a landmark January 2025 finding, an international commission concluded that classifying obesity as a single, uniform disease is incompatible with its varied manifestations, according to Nature .

Maria Flores·June 1, 2026

A glowing, complex quintuple agonist molecule in a futuristic lab, representing a breakthrough in obesity and diabetes treatment.

Cosmos & Physics

New Quintuple Agonist Shows Promise for Obesity and Diabetes in Mice

In obese mice, a single experimental drug molecule, a GLP-1R GIPR PPAR quintuple agonist, led to greater weight loss and better blood sugar control than semaglutide (Ozempic) and a standard GLP-1/GIP

Dr. Evelyn Reed·May 18, 2026